I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 4 studies | 29% ± 10% | |
| glutamatergic neuron | 3 studies | 24% ± 6% | |
| goblet cell | 3 studies | 20% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 4 studies | 29% ± 10% | |
| glutamatergic neuron | 3 studies | 24% ± 6% | |
| goblet cell | 3 studies | 20% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 2793.98 | 2642 / 2642 | 100% | 14.36 | 705 / 705 |
| esophagus | 100% | 2242.39 | 1445 / 1445 | 100% | 13.54 | 183 / 183 |
| ovary | 100% | 2136.50 | 180 / 180 | 100% | 11.27 | 430 / 430 |
| pancreas | 100% | 1907.25 | 328 / 328 | 100% | 16.88 | 178 / 178 |
| prostate | 100% | 2295.45 | 245 / 245 | 100% | 22.64 | 502 / 502 |
| breast | 100% | 2071.98 | 459 / 459 | 100% | 19.39 | 1116 / 1118 |
| liver | 100% | 2414.82 | 226 / 226 | 100% | 14.93 | 404 / 406 |
| intestine | 100% | 2892.43 | 966 / 966 | 99% | 13.50 | 522 / 527 |
| lung | 100% | 1613.18 | 576 / 578 | 99% | 10.18 | 1148 / 1155 |
| bladder | 100% | 1924.19 | 21 / 21 | 99% | 9.44 | 499 / 504 |
| stomach | 100% | 1956.15 | 359 / 359 | 99% | 14.28 | 283 / 286 |
| uterus | 100% | 3058.81 | 170 / 170 | 99% | 9.85 | 454 / 459 |
| thymus | 100% | 1544.34 | 653 / 653 | 98% | 9.20 | 595 / 605 |
| adrenal gland | 100% | 1670.71 | 258 / 258 | 98% | 13.50 | 226 / 230 |
| kidney | 100% | 1067.45 | 89 / 89 | 96% | 8.33 | 869 / 901 |
| skin | 100% | 1760.79 | 1809 / 1809 | 92% | 6.32 | 435 / 472 |
| adipose | 100% | 1916.92 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 100% | 1516.79 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1429.84 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 6.20 | 1 / 1 |
| blood vessel | 100% | 2025.98 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 2035.49 | 853 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 5.52 | 43 / 45 |
| eye | 0% | 0 | 0 / 0 | 91% | 6.85 | 73 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 90% | 5.01 | 26 / 29 |
| peripheral blood | 68% | 678.29 | 633 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0016567 | Biological process | protein ubiquitination |
| GO_0036503 | Biological process | ERAD pathway |
| GO_0007417 | Biological process | central nervous system development |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0061630 | Molecular function | ubiquitin protein ligase activity |
| GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | RNF103 |
| Protein name | E3 ubiquitin-protein ligase RNF103 (EC 2.3.2.27) (KF-1) (hKF-1) (RING finger protein 103) (RING-type E3 ubiquitin transferase RNF103) (Zinc finger protein 103 homolog) (Zfp-103) |
| Synonyms | ZFP103 |
| Description | FUNCTION: Acts as an E2-dependent E3 ubiquitin-protein ligase, probably involved in the ER-associated protein degradation pathway. . |
| Accessions | ENST00000237455.5 O00237 |
